(Q67491832)

English

A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy

scientific article published on 01 January 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. The Granisetron Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy (English)

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

cancer research

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

author name string

K. Bremer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320907

6 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1320907

6 December 2023

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0959804992904469?httpAccept=text/xml

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

https://api.elsevier.com/content/article/PII:0959804992904469?httpAccept=text/plain

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

28A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

6-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1018-1022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.

1

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

The symptomatic control of cytostatic drug-induced emesis. A recent history and review

2

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

The concept of selectivity in 5-HT receptor research

4

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis

5

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

New antiemetic drugs.

8

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis

9

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis

11

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

Activity of a new antiemetic agent: alizapride

16

1 reference

10.1016/0959-8049(92)90446-9

https://api.crossref.org/works/10.1016/0959-8049(92)90446-9

6 December 2023

Identifiers

10.1016/0959-8049(92)90446-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320907%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67491832&oldid=2025405144"